Ocean Biomedical Inc
NASDAQ:OCEA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
O
|
Ocean Biomedical Inc
NASDAQ:OCEA
|
255.6k USD |
Loading...
|
|
| IN |
A
|
Aaswa Trading and Exports Ltd
BSE:512038
|
26.9T INR |
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
193.6B USD |
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
72B USD |
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
55.2B USD |
Loading...
|
|
| IN |
G
|
GTV Engineering Ltd
BSE:539479
|
4.5T INR |
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
46.2B USD |
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
34.1B CHF |
Loading...
|
|
| US |
R
|
Reddit Inc
NYSE:RDDT
|
34.2B USD |
Loading...
|
Market Distribution
Other Profitability Ratios
Ocean Biomedical Inc
Glance View
Ocean Biomedical, Inc. is a biopharmaceutical company. The company is headquartered in Providence, Rhode Island. The company went IPO on 2021-09-15. The firm is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The firm helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). The company offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.